Long-Term Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor-α Modulator (SPPARMα), in Dyslipidemic Patients with Renal Impairment

Pemafibrate (K-877) is a novel selective peroxisome proliferator-activated receptor-α modulator (SPPARMα) with a favorable benefit-risk balance. Previous clinical trials of pemafibrate used stringent exclusion criteria related to renal functions. Therefore, we investigated its safety and efficacy in...

Descripción completa

Detalles Bibliográficos
Autores principales: Yokote, Koutaro, Yamashita, Shizuya, Arai, Hidenori, Araki, Eiichi, Suganami, Hideki, Ishibashi, Shun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6386904/
https://www.ncbi.nlm.nih.gov/pubmed/30736366
http://dx.doi.org/10.3390/ijms20030706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6386904/
https://www.ncbi.nlm.nih.gov/pubmed/30736366
http://dx.doi.org/10.3390/ijms20030706

Ejemplares similares